The role of zinc in liver cirrhosis

Leoni, 2014, Zinc proteome interaction network as a model to identify nutrient-affected pathways in human pathologies, Genes Nutr, 9, 436, 10.1007/s12263-014-0436-0 Maret, 2013, Zinc in Human Disease, Met Ions Life Sci, 13, 389, 10.1007/978-94-007-7500-8_12 Rink, 2007, Zinc homeostasis and immunity, Trends Immunol, 28, 1, 10.1016/j.it.2006.11.005 Brown KH, Wuehler SE. Zinc and Human Health: The Results of Recent Trials and Implications for Program Interventions and Research, Ottawa: Micronutrient Initiative; 2000, p. 1-69. World Health Report 2002. Reducing Risks, Promoting Healthy Life. Geneva: WHO; 2002, p. 1-250. Grüngreiff, 2011, Zinc and Liver, 473 Maret, 2004, Zinc and sulphur: A critical partnership, Biochemistry, 43, 3301, 10.1021/bi036340p Stehben, 2003, Oxidative stress, toxic hepatitis and antioxidants with particular emphasis on zinc, Exp Mol Pathol, 75, 265, 10.1016/S0014-4800(03)00097-2 Powell, 2000, The antioxidant properties of zinc, Nutr, 130, 1447S Grüngreiff K, Reinhold D. Zink: Bedeutung in der ärztlichen Praxis. Heßdorf-Klebheim: J. Hartmann Verlag; 2007, p. 1-96. Buchinger, 1988, Veränderungen des Zinkspiegels im Serum, Vollblut und im Erythrozyten bei Schilddrüsenstoffwechselstörungen, Wien Klin Wochenschr, 100, 619 Faure, 1991, Effect of acute zinc depletion on rat lipoprotein distribution and peroxidation, Biol Trace Elem Res, 28, 135, 10.1007/BF02863079 Köttgen, 1984, Zink und Vitamin A, Z Allg Med, 60, 1043 Prasad, 1991, Discovery of human zinc deficiency and studies in an experimental human model, Am J Clin Med, 53, 403 Danscher, 2005, Zinc-specific autometallographic in vivo selenium methods: tracing of zinc-enriched (ZEN) terminals, ZEN pathways, and pools of zinc ions in a multitude of other ZEN cells, Cytochem Histochem, 53, 141, 10.1369/jhc.4R6460.2005 Fukada, 2011, Zinc homeostasis and signaling in health and diseases, J Biol Inorg Chem, 16, 1123, 10.1007/s00775-011-0797-4 Rink, 2011, Introduction-Why Investigate Zinc, 3 Grüngreiff K. Zinc and Liver. Freiburg: Dr. Falk Pharma GmbH; 2013, p. 1-84. Huber, 2012, Mechanism of zinc-mediated inhibition of caspase-9, ProteinSci, 21, 1056, 10.1002/pro.2090 Beyersmann, 2001, Functions of zinc in signaling, proliferation and differentiation of mammalian cells, BioMetals, 14, 331, 10.1023/A:1012905406548 Maret, 2006, Zinc coordination environments in proteins as redox sensors and signal transducers, Antioxid Redox Signal, 8, 1419, 10.1089/ars.2006.8.1419 Maret, 2011, Human Zinc Biochemistry, 45 Cousins, 2011, Zinc transporters, 163 Liuzzi, 2004, Mammalian zinc transporters, Annu Rev Nutr, 24, 151, 10.1146/annurev.nutr.24.012003.132402 Lichten, 2009, Mammalian zinc transporters: nutritional and physiologic regulation, Annu Rev Nutr, 29, 153, 10.1146/annurev-nutr-033009-083312 Maret, 2011, Metals on the move: zinc ions in cellular regulation and in the coordination dynamics of zinc proteins, BioMetals, 24, 411, 10.1007/s10534-010-9406-1 Foster, 2011, Zinc transporter genes are coordinately expressed in men and women independently of dietary or plasma zinc, J Nutr, 141, 1195, 10.3945/jn.111.140053 Ho, 2004, Zinc deficiency, DNA damage and cancer risk, J Nutr Biochem, 15, 572, 10.1016/j.jnutbio.2004.07.005 Tuerk, 2009, Zinc deficiency, Curr Opin Gastroenterol, 25, 136, 10.1097/MOG.0b013e328321b395 Taylor, 1994, The mechanisms of zinc uptake by cultured rat liver cells, J Physiol, 474, 55, 10.1113/jphysiol.1994.sp020002 Cousins, 1985, Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin, Physiol Rev, 65, 238, 10.1152/physrev.1985.65.2.238 tom Dieck, 2003, Changes in rat hepatic gene expression in response to zinc deficiency as assessed by DNA arrays, J Nutr, 133, 1004, 10.1093/jn/133.4.1004 Liuzzi, 2005, Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response, Proc Natl Acad Sci, 102, 6843, 10.1073/pnas.0502257102 Nemeth, 2004, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Science, 306, 2090, 10.1126/science.1104742 Hentze, 2004, Balancing acts: molecular control of mammalian iron metabolism, Cell, 117, 285, 10.1016/S0092-8674(04)00343-5 Aydemir, 2012, The Zinc Transporter zip 14 Influences c-Met Phosphorylation and Hepatocyte Proliferation during Liver Regeneration in Mice, Gastroenterology, 142, 1536, 10.1053/j.gastro.2012.02.046 Franklin, 2012, ZIP14 zinc transporter down regulation and zinc depletion in the development and progression of hepatocellular cancer, J Gastrointest Cancer, 43, 249, 10.1007/s12029-011-9269-x Cuthberson, 1972, Metabolism after injury. 1. Effects of severity, nutrition and enviromental temperature on protein, potassium, zinc, and creatine, Br J Surg, 59, 925, 10.1002/bjs.1800591202 Barry, 1990, Tissue zinc status and drug elimination in patients with chronic liver disease, Clin Sci, 78, 547, 10.1042/cs0780547 Oteiza, 2005, Zinc, oxidant-triggered cell signalling, and human health, Mol Aspects Med, 26, 245, 10.1016/j.mam.2005.07.012 DiSilvestro, 2000, Zinc in relation to diabetes and oxidative disease, J Nutr, 130, 1509S, 10.1093/jn/130.5.1509S Parsons, 1994, Effects of mild zinc deficiency, plus or minus an acute-phase response on galactosamineinduced hepatitis in rats, Br Nutr, 72, 611, 10.1079/BJN19940063 Mohammad, 2012, Zinc and Liver Disease, Nutr Clin Pract, 27, 8, 10.1177/0884533611433534 Gaetke, 1997, Effects of endotoxin on zinc metabolism in human volunteers, Am Physiol, 272, E952 McClain, 1993, Zinc in the stress response, Scand J Work Environ Health, 19, 132 Albillos, 2014, Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance, J Hepatol, 61, 1385, 10.1016/j.jhep.2014.08.010 Jenne, 2013, Immune surveillance by the liver, Nat Immunol, 4, 996, 10.1038/ni.2691 Racanelli, 2006, The liver as an immunological organ, Hepatology, 43, S54, 10.1002/hep.21060 Wiest, 2014, Pathological translocation in liver cirrhosis, J Hepatol, 60, 197, 10.1016/j.jhep.2013.07.044 Amodio, 2013, The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus, Hepatology, 58, 325, 10.1002/hep.26370 Bémeur, 2010, Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure, J Nutr Metab, 2010, ID489823, 10.1155/2010/489823 O’Brien, 2008, Nutrition in end-stage liver disease: principles and practice, Gastroenterology, 134, 1729, 10.1053/j.gastro.2008.02.001 Grüngreiff, 1989, Correlations between zinc, amino acids and ammonia in liver cirrhosis, Z Gastroenterol, 27, 731 Buchman, 2006, Total parenteral nutrition: challenges and practice in the cirrhotic patient, Transplant Proc, 38, 1659, 10.1016/j.transproceed.2006.05.030 Hayashi, 2007, Evaluation of the effects of combination therapy with branched-chain amino acid and zinc supplements on nitrogen metabolism in liver cirrhosis, Hepatol Res, 37, 615, 10.1111/j.1872-034X.2007.00095.x Itou, 2009, Branched-chain amino acid supplements reduced ascites and increased the quality of life in a patient with liver cirrhosis: A case report, Mol Med Rep, 2, 977 Bianchi, 2008, Nutritional treatment of chronic liver failure, Hepatol Res, 38, 93, 10.1111/j.1872-034X.2008.00433.x Garcia-Martinez, 2013, Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications, Hepatology, 58, 1836, 10.1002/hep.26338 Bal, 2013, Binding of transition metal ions to albumin: sites, affinities and rates, Biochim Biophys Acta, 1830, 5444, 10.1016/j.bbagen.2013.06.018 Lu, 2008, Albumin as a zinc carrier: properties of its high-affinity zinc-binding site, Biochem Soc Trans, 36, 1317, 10.1042/BST0361317 Cousins, 1986, Toward a molecular understanding of zinc metabolism, Clin Physiol Biochem, 4, 20 Grüngreiff, 1991, Zinc deficiency-A factor in the pathogenesis of hepatic encephalopathy, Z Gastroenterol, 29, 101 Tajiri, 2013, Branched-chain amino acids in liver diseases, World J Gastroenterol, 19, 7620, 10.3748/wjg.v19.i43.7620 Holecek, 2013, Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications, Nutrition, 29, 1186, 10.1016/j.nut.2013.01.022 Hara, 1998, Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism, J Biol Chem, 273, 14484, 10.1074/jbc.273.23.14484 Kuwahata, 2012, Effect of branched-chain amino acid supplementation on the oxidized/reduced state of plasma albumin in rats with chronic liver disease, J Clin Biochem Nutr, 50, 67, 10.3164/jcbn.11-37 Takuma, 2010, Clinical trial: oral zinc in hepatic encephalopathy, Aliment Pharmacol Ther, 32, 1080, 10.1111/j.1365-2036.2010.04448.x Padula, 2014, Protein Energy Malnutrition. Does the in vitro Zinc Sulfate Supplementation Improve Chromosomal Damage repair, Biol Trace Elem Res, 162, 64, 10.1007/s12011-014-0109-2 Riggio, 2010, Hepatic encephalopathy therapy: An overview, World J Gastrointest Pharmacol Ther, 1, 54, 10.4292/wjgpt.v1.i2.54 Schliess, 2009, RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia, Metab Brain Dis, 24, 119, 10.1007/s11011-008-9125-2 Shawcross, 2010, Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis, Hepatology, 51, 1062, 10.1002/hep.23367 Rabbani, 1978, Plasma ammonia and liver ornithine transcarbamoylase activity in zinc-deficient rats, Am J Physiol, 235, E203 Riggio, 1992, Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis, Hepatology, 16, 785, 10.1002/hep.1840160326 Prasad, 1982, Clinical disorders of zinc deficiency, 89 Yoshida, 2001, Feefects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis, Acta Med Okayama, 55, 349 Marchesini, 1996, Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis, Hepatology, 23, 1084, 10.1002/hep.510230523 Reding, 1984, Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial, Lancet, 2, 493, 10.1016/S0140-6736(84)92567-4 Van der Rijt, 1991, Overt hepatic encephalopathy precipitated by zinc deficiency, Gastroenterology, 100, 1114, 10.1016/0016-5085(91)90290-2 Riggio, 1991, Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial, Dig Dis Sci, 36, 1204, 10.1007/BF01307509 Kugelmas, 2000, Preliminary observation: Oral zinc sulfate replacement is effective in treating muscle cramps in cirrhotic patients, J Am Coll Nutr, 19, 13, 10.1080/07315724.2000.10718908 Katayama, 2014, Effect of zinc on liver cirrhosis with hyperammonemia: A preliminary randomized, placebo controlled double-blind trial, Nutrition, 30, 1409, 10.1016/j.nut.2014.04.018 El-Serag, 2011, Hepatocellular carcinoma, N Engl J Med, 365, 1118, 10.1056/NEJMra1001683 Toyokuni, 2009, Role of iron in carcinogenesis: cancer as a ferrotoxic disease, Cancer Sci, 100, 9, 10.1111/j.1349-7006.2008.01001.x Georgakilas, 2010, Viral-induced human carcinogenesis: an oxidative stress perspective, Mol Biosyst, 6, 1162, 10.1039/b923958h El Serag, 2014, Epidemiology of Hepatocellular Carcinoma in the United States. Where are we? Where do we go, Hepatology, 60, 1767 Ebara, 2000, Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma, J Hepatol, 33, 415, 10.1016/S0168-8278(00)80277-9 Galloway, 2000, Effect of the inflammatory response on trace element and vitamin status, Ann Clin Biochem, 37, 289, 10.1258/0004563001899429 Grüngreiff, 2009, Plasma concentrations of zinc, copper, interleukin-6 and interferon-gamma, and plasma dipeptidyl peptidase IV activity in chronic hepatitis C, Mol Med Report, 2, 63 Jie, 2007, Evaluation of Cu in hepatocellular carcinoma by particle induced X-ray emission, J Trace Elem Med Biol, 21, 255, 10.1016/j.jtemb.2007.06.004 Overbeck, 2008, Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases, Arch Immunol Ther Exp, 56, 15, 10.1007/s00005-008-0003-8 Taylor, 2011, Zinc and cancer, 283 Zhang, 2010, ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts, Cancer Biol Ther, 9, 236, 10.4161/cbt.9.3.10749 Hogstrand, 2009, Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation, Trends Mol Med, 15, 101, 10.1016/j.molmed.2009.01.004 Schouwink G. De hepato-cerebrale degeneratie. Thesis, University of Amsterdam, 1961. Hoogenard, 2006, Paradigm shift in treatment of Wilsons disease: zinc therapy now treatment of choice, Brain Dev, 8, 141, 10.1016/j.braindev.2005.08.008 Huster, 2010, Wilson disease, Best Pract Res Clin Gastroenterol, 24, 531, 10.1016/j.bpg.2010.07.014 Iorio, 2015, Wilson disease: A Matter of Copper, But Also of Zinc, J Pediatr Gastroenterol Nutr, 60, 423, 10.1097/MPG.0000000000000725 Marcellini, 2005, Treatment of Wilson’s disease with zinc from the time of diagnosis in pediatrics patients: A single hospital 10-year follow up study, J Lab Clin Med, 145, 139, 10.1016/j.lab.2005.01.007 Ranucci, 2014, Wilson disease: what is unclear in pediatric patients, Clin Res Hepatol Gastroenterol, 38, 268, 10.1016/j.clinre.2014.03.002 Castillo-Higuerto, 2000, Acute hepatitis after starting zinc therapy in a patient with presymptomatic Wilson’s disease, Hepatology, 32, 877, 10.1053/jhep.2000.17917 Roberts, 2011, Zinc toxicity: from “no, never” to “hardly fever”, Gastroenterology, 140, 1132, 10.1053/j.gastro.2011.02.028 Prasad, 2013, Discovery of human zinc deficiency: impact on human health and disease, Adv Nutr, 4, 176, 10.3945/an.112.003210